<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>7121</number>
    <updateDate>2022-12-29T22:03:50Z</updateDate>
    <updateDateIncludingText>2022-12-29T22:03:50Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <type>HR</type>
    <introducedDate>2022-03-17</introducedDate>
    <congress>117</congress>
    <constitutionalAuthorityStatementText>
      <![CDATA[<pre>[Congressional Record Volume 168, Number 48 (Thursday, March 17, 2022)][House]From the Congressional Record Online through the Government Publishing Office [<a href="https://www.gpo.gov">www.gpo.gov</a>]By Mr. GALLAGHER:H.R. 7121.Congress has the power to enact this legislation pursuantto the following:The Interstate Commerce Clause: Clause 3 of Section 8 ofArticle I.[Page H3828]</pre>]]>
    </constitutionalAuthorityStatementText>
    <committees>
      <item>
        <systemCode>hsvr00</systemCode>
        <name>Veterans' Affairs Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hsvr03</systemCode>
            <name>Health Subcommittee</name>
            <activities>
              <item>
                <name>Referred to</name>
                <date>2022-03-28T13:56:37Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2022-03-17T14:03:00Z</date>
          </item>
        </activities>
      </item>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
            <activities>
              <item>
                <name>Referred to</name>
                <date>2022-03-18T15:08:52Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2022-03-17T14:02:45Z</date>
          </item>
        </activities>
      </item>
      <item>
        <systemCode>hsas00</systemCode>
        <name>Armed Services Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2022-03-17T14:03:05Z</date>
          </item>
        </activities>
      </item>
      <item>
        <systemCode>hswm00</systemCode>
        <name>Ways and Means Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2022-03-17T14:02:50Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>Protecting our Pharmaceutical Supply Chain from China Act of 2021</title>
        <congress>117</congress>
        <number>2495</number>
        <type>S</type>
        <latestAction>
          <actionDate>2021-07-28</actionDate>
          <text>Read twice and referred to the Committee on Finance.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>ABC Safe Drug Act</title>
        <congress>117</congress>
        <number>3401</number>
        <type>S</type>
        <latestAction>
          <actionDate>2021-12-15</actionDate>
          <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2022-03-28</actionDate>
        <committees>
          <item>
            <systemCode>hsvr03</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2022-03-18</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2022-03-17</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Veterans' Affairs, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsas00</systemCode>
            <name>Armed Services Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2022-03-17</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Veterans' Affairs, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsvr00</systemCode>
            <name>Veterans' Affairs Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2022-03-17</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Veterans' Affairs, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hswm00</systemCode>
            <name>Ways and Means Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2022-03-17</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Veterans' Affairs, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2022-03-17</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2022-03-17</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>G000579</bioguideId>
        <fullName>Rep. Gallagher, Mike [R-WI-8]</fullName>
        <firstName>Mike</firstName>
        <lastName>Gallagher</lastName>
        <party>R</party>
        <state>WI</state>
        <identifiers>
          <bioguideId>G000579</bioguideId>
        </identifiers>
        <district>8</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>S001196</bioguideId>
        <fullName>Rep. Stefanik, Elise M. [R-NY-21]</fullName>
        <firstName>Elise</firstName>
        <lastName>Stefanik</lastName>
        <party>R</party>
        <state>NY</state>
        <identifiers>
          <bioguideId>S001196</bioguideId>
        </identifiers>
        <middleName>M.</middleName>
        <district>21</district>
        <sponsorshipDate>2022-03-17</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>C001109</bioguideId>
        <fullName>Rep. Cheney, Liz [R-WY-At Large]</fullName>
        <firstName>Liz</firstName>
        <lastName>Cheney</lastName>
        <party>R</party>
        <state>WY</state>
        <identifiers>
          <bioguideId>C001109</bioguideId>
        </identifiers>
        <district>0</district>
        <sponsorshipDate>2022-03-17</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B001305</bioguideId>
        <fullName>Rep. Budd, Ted [R-NC-13]</fullName>
        <firstName>Ted</firstName>
        <lastName>Budd</lastName>
        <party>R</party>
        <state>NC</state>
        <identifiers>
          <bioguideId>B001305</bioguideId>
        </identifiers>
        <district>13</district>
        <sponsorshipDate>2022-03-17</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>V000133</bioguideId>
        <fullName>Rep. Van Drew, Jefferson [R-NJ-2]</fullName>
        <firstName>Jefferson</firstName>
        <lastName>Van Drew</lastName>
        <party>R</party>
        <state>NJ</state>
        <identifiers>
          <bioguideId>V000133</bioguideId>
        </identifiers>
        <district>2</district>
        <sponsorshipDate>2022-03-17</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>H001053</bioguideId>
        <fullName>Rep. Hartzler, Vicky [R-MO-4]</fullName>
        <firstName>Vicky</firstName>
        <lastName>Hartzler</lastName>
        <party>R</party>
        <state>MO</state>
        <identifiers>
          <bioguideId>H001053</bioguideId>
        </identifiers>
        <district>4</district>
        <sponsorshipDate>2022-03-17</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>P000599</bioguideId>
        <fullName>Rep. Posey, Bill [R-FL-8]</fullName>
        <firstName>Bill</firstName>
        <lastName>Posey</lastName>
        <party>R</party>
        <state>FL</state>
        <identifiers>
          <bioguideId>P000599</bioguideId>
        </identifiers>
        <district>8</district>
        <sponsorshipDate>2022-03-17</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>H001086</bioguideId>
        <fullName>Rep. Harshbarger, Diana [R-TN-1]</fullName>
        <firstName>Diana</firstName>
        <lastName>Harshbarger</lastName>
        <party>R</party>
        <state>TN</state>
        <identifiers>
          <bioguideId>H001086</bioguideId>
        </identifiers>
        <district>1</district>
        <sponsorshipDate>2022-05-11</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B001291</bioguideId>
        <fullName>Rep. Babin, Brian [R-TX-36]</fullName>
        <firstName>Brian</firstName>
        <lastName>Babin</lastName>
        <party>R</party>
        <state>TX</state>
        <identifiers>
          <bioguideId>B001291</bioguideId>
        </identifiers>
        <district>36</district>
        <sponsorshipDate>2022-06-23</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Asia</name>
        </item>
        <item>
          <name>Business expenses</name>
        </item>
        <item>
          <name>China</name>
        </item>
        <item>
          <name>Drug safety, medical device, and laboratory regulation</name>
        </item>
        <item>
          <name>Government information and archives</name>
        </item>
        <item>
          <name>Health care costs and insurance</name>
        </item>
        <item>
          <name>Health programs administration and funding</name>
        </item>
        <item>
          <name>Health technology, devices, supplies</name>
        </item>
        <item>
          <name>Income tax deductions</name>
        </item>
        <item>
          <name>Manufacturing</name>
        </item>
        <item>
          <name>Military medicine</name>
        </item>
        <item>
          <name>Military procurement, research, weapons development</name>
        </item>
        <item>
          <name>Prescription drugs</name>
        </item>
        <item>
          <name>Public contracts and procurement</name>
        </item>
        <item>
          <name>Trade restrictions</name>
        </item>
        <item>
          <name>Veterans' medical care</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2022-03-17</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2022-07-26T10:28:24Z</updateDate>
        <text>
          <![CDATA[ <p><strong>Protecting </strong><strong>o</strong><strong>ur Pharmaceutical Supply Chain from China Act of 2022</strong></p> <p>This bill requires the federal government to maintain a registry of certain foreign-sourced drugs, prohibits federal health care programs from purchasing drugs containing ingredients manufactured in China, requires drugs to be labeled for country of origin, and offers domestic manufacturing facility tax incentives.</p> <p>The Food and Drug Administration shall maintain (1) a list of foreign-sourced drugs and active ingredients that are critical for consumer health and safety, and (2) another list identifying such drugs that are produced exclusively in China or use ingredients produced in China. </p> <p>The bill phases in a restriction on federal health care programs purchasing drugs with active ingredients manufactured in China. By January 1, 2024, such programs may not purchase a drug with any active ingredients from China. The Department of Health and Human Services may issue a waiver for an agency or program that is unable to meet this requirement, but no waiver may apply to drugs purchased in or after 2026.</p> <p>Each drug must have labeling listing the country of origin of each active ingredient, and a drug without this labeling shall be deemed misbranded. </p> <p>The bill allows 100% tax expensing for qualified pharmaceutical and medical device manufacturing property placed in service between 2020 and 2026. </p>]]>
        </text>
      </summary>
    </summaries>
    <title>Protecting our Pharmaceutical Supply Chain from China Act of 2022</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Protecting our Pharmaceutical Supply Chain from China Act of 2022</title>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <title>Protecting our Pharmaceutical Supply Chain from China Act of 2022</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To require the Secretary of Health and Human Services to maintain a list of the country of origin of all drugs marketed in the United States, to ban the use of Federal funds for the purchase of drugs manufactured in the People's Republic of China, and for other purposes.</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2022-03-17T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-117hr7121ih/xml/BILLS-117hr7121ih.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <date/>
        <formats/>
        <type/>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2022-03-28</actionDate>
      <text>Referred to the Subcommittee on Health.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
